JPMorgan Chase & Co’s Mereo BioPharma MREO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-365
| Closed | -$821 | – | 6450 |
|
|
2025
Q1 | $821 | Hold |
365
| – | – | ﹤0.01% | 5775 |
|
|
2024
Q4 | $1.28K | Hold |
365
| – | – | ﹤0.01% | 5645 |
|
|
2024
Q3 | $1.5K | Hold |
365
| – | – | ﹤0.01% | 5601 |
|
|
2024
Q2 | $1.31K | Sell |
365
-37,757
| -99% | -$136K | ﹤0.01% | 5557 |
|
|
2024
Q1 | $126K | Buy |
38,122
+19,004
| +99% | +$62.7K | ﹤0.01% | 4641 |
|
|
2023
Q4 | $44.2K | Sell |
19,118
-113,683
| -86% | -$263K | ﹤0.01% | 5046 |
|
|
2023
Q3 | $171K | Sell |
132,801
-171,230
| -56% | -$221K | ﹤0.01% | 4315 |
|
|
2023
Q2 | $401K | Sell |
304,031
-123,102
| -29% | -$162K | ﹤0.01% | 3876 |
|
|
2023
Q1 | $302K | Buy |
427,133
+281,874
| +194% | +$199K | ﹤0.01% | 4090 |
|
|
2022
Q4 | $77K | Buy |
145,259
+132,757
| +1,062% | +$70.4K | ﹤0.01% | 4581 |
|
|
2022
Q3 | $10K | Buy |
12,502
+7,922
| +173% | +$6.34K | ﹤0.01% | 5071 |
|
|
2022
Q2 | $5K | Sell |
4,580
-8,582
| -65% | -$9.37K | ﹤0.01% | 5311 |
|
|
2022
Q1 | $15K | Buy |
13,162
+368
| +3% | +$419 | ﹤0.01% | 5314 |
|
|
2021
Q4 | $21K | Buy |
12,794
+9,794
| +326% | +$16.1K | ﹤0.01% | 5311 |
|
|
2021
Q3 | $7K | Buy |
+3,000
| New | +$7K | ﹤0.01% | 5280 |
|